Cargando…
Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B
Immunogenicity of vaccines against meningococcal serogroup B (MenB) has been assessed pre-licensure with a human serum bactericidal activity assay (hSBA), tested against small numbers of strains. We report the qualification/validation of an alternative qualitative hSBA which uses endogenous compleme...
Autores principales: | Kleinschmidt, Annett, Vadivelu, Kumaran, Serino, Laura, Neidig, Nina, de Wergifosse, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902841/ https://www.ncbi.nlm.nih.gov/pubmed/33623041 http://dx.doi.org/10.1038/s41541-021-00286-8 |
Ejemplares similares
-
1638. Development of a Model to Estimate Persistence of hSBA Titers Over Time Following a Primary Series and Booster Dose of the Pentavalent Meningococcal MenABCWY Vaccine
por: Cai, Bing, et al.
Publicado: (2023) -
A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model
por: Argante, Lorenzo, et al.
Publicado: (2021) -
1994. Development of a Meningococcal Serogroup B Serum Bactericidal Assay Using Fetal Bovine Serum
por: Kim, Han Wool, et al.
Publicado: (2018) -
Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
por: Neri, Arianna, et al.
Publicado: (2022) -
01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)